Filing Flows

Filing Flows › Humacyte (HUMA) › Next earnings date

Humacyte (HUMA) earnings on Nov 10, 2026: what to expect

Humacyte (HUMA) is expected to report earnings on Nov 10, 2026, in 2 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.08 (−$0.10 to −$0.06, 4 estimates) on revenue of $770K, against −$0.11 and $753K a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 75% chance of beating next time.

Report dateNov 10, 2026
Days to go2
EPS estimate−$0.08
Revenue estimate$770K
Beat rate75%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Humacyte: revenue lines, growth year over year, Q2 2026Humacyte: revenue lines, growth year over year, Q2 2026Revenue+35%

Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$0.11 on revenue of $890K, against the analysts' −$0.08.

The last report

Humacyte reported revenue of $406K for the second quarter 2026 (+35% Y/Y), net loss $36.8M. How it makes money → · Every quarter →

Humacyte: EPS against the estimate, last 4 reportsHumacyte: EPS against the estimate, last 4 reportsEstimateReported−$0.15−$0.11Nov 25−$0.14−$0.13Mar 26−$0.12−$0.09May 26−$0.10−$0.16Aug 26
Latest (Aug 26): Estimate −$0.10, Reported −$0.16.

Humacyte's latest quarter

Humacyte, Q2 2026: revenue $406K (+35% year over year), net loss $36.8M, operating cash flow −$22.1M. The chart follows the revenue to costs, profit and cash.

Questions

When does HUMA report earnings?

Humacyte is expected to report on Nov 10, 2026.

What are analysts expecting from Humacyte?

EPS of −$0.08 and revenue of $770K for the quarter.

Does Humacyte usually beat earnings?

It beat the consensus EPS estimate in 75% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.